HONG KONG--(BUSINESS WIRE)--Cavion, Inc., a leading clinical stage biotechnology company committed to developing novel therapeutics for people with neurological diseases, today announced promising ...
Pennsylvania officials continue to retool the state’s vaccination plan to fall in line with recommendations from federal groups and further define who can get the vaccine and when, releasing the ...
Fred Hutchinson Cancer Center leads the way when it comes to offering eligible patients alternative options when conventional therapies no longer work. With more than two dozen phase 1 clinical trials ...
NORTH CHICAGO, Ill., Oct. 6, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced positive topline results from the Phase 2 ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA (BOTOX®) ...
Success by nearly all measures with Praxis Precision Medicines Inc.’s essential tremor phase III candidate, ulixacaltamide, drove the company’s stock up by more than 200% and provided supportive data ...
CHARLOTTESVILLE, Va. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cavion, Inc., a leading clinical stage biotechnology company committed to developing novel therapeutics for people with neurological diseases, ...
Here are the top 5 articles detailing the advancements in hematologic oncology from 2025. BTK inhibitors have revolutionized ...
Gov. John Bel Edwards announced Monday the state's stay-home order will be lifted as the state moves into phase one of reopening Louisiana on Friday. As part of the phase one, many types of business ...
ATLANTA — Mayor Keisha Lance Bottoms has rolled back the city’s reopening plans from Phase 2 back to Phase 1 effective immediately as coronavirus cases surge, she announced Friday night. In Phase 1, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback